Michelle L. McGowan, PhD; Associate Professor of Pediatrics and Women's, Gender, and Sexuality Studies; University of Cincinnati
Aarti Ramdaney, MS, CGC; Assistant Professor of Obstetrics, Gynecology and Reproductive Sciences; McGovern Medical School at The University of Texas Health Science Center at Houston
Kimberly Mutcherson, JD; Co-Dean and Professor of Law; Rutgers University
The Supreme Court’s anticipated decision in Dobbs v. Jackson Women’s Health is likely to change the landscape of clinical practice in prenatal genomic medicine. With the prospect of the overturning of Roe v. Wade and other key precedents that have protected the right to choose, America faces a collision between the technical possibilities of genomics and laws affecting reproductive health. Clinicians, prospective parents, and pregnant patients may experience vastly different reproductive healthcare than has been available over the past three decades. This webinar explores the ethical, legal, and social challenges of this anticipated decision for clinicians, patients, and families. Lessons will be drawn from research in states with existing restrictive abortion laws. It will also consider how the decision may affect the training of genetic counselors and health providers in reproductive genomics and its likely effects on efforts to expand genomic medicine and assure tailored genomic care. These concerns will be explored with reference to the varying laws and policies across states, as well as the diverse populations that seek reproductive services and care.
View online here.
ELSI Hub Friday Forum sponsored by NHGRI